GeneDx will target eligible patients for upfront testing using clinical and genomic data, aiming to reduce sequential tests and close diagnostic gaps.

View GeneDx Holdings Corp. Class A WGS stock quote prices, financial information, real-time forecasts, and company news from CNN.

Research also covers more than 19,000 newborns and nine abstracts on gene discovery; results remain under embargo until their ASHG sessions begin.

GAITHERSBURG, Md., October 19, 2026--GeneDx, the leader in rare disease diagnosis and improving health through the power of genomic data, today announced 27 accepted scientific abstracts at the American Society of Human Genetics (ASHG) 2026 Annual Meeting, highlighting how exome and genome sequencing are advancing scientific discovery, earlier diagnosis and more precise care.

Los altos costos de los intereses están presionando a los gobiernos y a los hogares, pero la atención sanitaria sigue siendo un gasto no discrecional que la gente rara vez recorta. Esa combinación mantiene la atención en negocios médicos financieramente sólidos con una demanda resistente de tratamientos, equipos y servicios. La oportunidad es clara para los inversores que quieran exponerse a este tema sin tener que examinar cientos de tickers. Este artículo destaca tres de las acciones de atención médica más sólidas de nuestro evaluador seleccionado. Los tres...

Price-action only: Genedx Holdings Corp. (WGS) movements set the tone for institutional models. (WGS) Movement Within Algorithmic Entry Frameworks